Dynamic Changes in Gut Microbiome of Ulcerative Colitis: Initial Study from Animal Model

References

• Atreya R, Siegmund B. Location is important: differentiation between ileal and colonic Crohn’s disease. Nat Rev Gastroenterol Hepatol. 2021;18:544–558. doi:10.1038/s41575-021-00424-6
   PubMed Web of Science ®Google Scholar
• American Gastroenterological Association. Management of mild-to-moderate ulcerative colitis: patient guide. Gastroenterology. 2019;156(3):766–767. doi:10.1053/j.gastro.2019.01.036
   PubMed Web of Science ®Google Scholar
• Al-Horani R, Spanudakis E, Hamad B. The market for ulcerative colitis. Nat Rev Drug Discov. 2022;21(1):15–16. doi:10.1038/d41573-021-00194-5
   PubMed Web of Science ®Google Scholar
• Cleveland NK, Torres J, Rubin DT. What does disease progression look like in ulcerative colitis, and how might it be prevented? Gastroenterology. 2022;162(5):1396–1408.
   PubMed Web of Science ®Google Scholar
• Cui G, Yuan A. A systematic review of epidemiology and risk factors associated with Chinese inflammatory bowel disease. Front Med. 2018;5:183. doi:10.3389/fmed.2018.00183
   PubMed Web of Science ®Google Scholar
• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi:10.1016/S0140-6736(17)32448-0
   PubMed Web of Science ®Google Scholar
• Neurath MF. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nat Immunol. 2019;20(8):970–979. doi:10.1038/s41590-019-0415-0
   PubMed Web of Science ®Google Scholar
• APDW2004 Chinese IBD Working Group. Retrospective analysis of 515 cases of Crohn’s disease hospitalization in China: nationwide study from 1990 to 2003. J Gastroenterol Hepatol. 2006;21(6):1009–1015. doi:10.1111/j.1440-1746.2006.04140.x
   PubMed Web of Science ®Google Scholar
• Short SP, Pilat JM, Barrett CW, et al. Colonic epithelial-derived selenoprotein P is the source for antioxidant-mediated protection in colitis-associated cancer. Gastroenterology. 2021;160:1694–1708.e3. doi:10.1053/j.gastro.2020.12.059
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Siegmund B, Le Berre C, et al. Ulcerative colitis. Nat Rev Dis Primers. 2020;6(1):74. doi:10.1038/s41572-020-0205-x
   PubMed Web of Science ®Google Scholar
• Damas OM, Abreu MT. Are patients with ulcerative colitis still at increased risk of colon cancer? Lancet. 2020;395(10218):92–94. doi:10.1016/S0140-6736(19)33225-8
   PubMed Web of Science ®Google Scholar
• Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48(4):526–535. doi:10.1136/gut.48.4.526
   PubMed Web of Science ®Google Scholar
• Galipeau HJ, Caminero A, Turpin W, et al. Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis. Gastroenterology. 2020;160:1532–1545. doi:10.1053/j.gastro.2020.12.004
   PubMed Web of Science ®Google Scholar
• He X, Gao J, Peng L, et al. Bacterial O-GlcNAcase genes abundance decreases in ulcerative colitis patients and its administration ameliorates colitis in mice. Gut. 2020;70(10):1872–1883.
   PubMed Web of Science ®Google Scholar
• Hovhannisyan Z, Treatman J, Littman DR, Mayer L. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology. 2011;140(3):957–965. doi:10.1053/j.gastro.2010.12.002
   PubMed Web of Science ®Google Scholar
• Nakase H, Sato N, Mizuno N, Ikawa Y. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmun Rev. 2022;21(3):103017. doi:10.1016/j.autrev.2021.103017
   PubMed Web of Science ®Google Scholar
• Annese V. Genetics and epigenetics of IBD. Pharmacol Res. 2020;159:104892. doi:10.1016/j.phrs.2020.104892
   PubMed Web of Science ®Google Scholar
• Quigley EM. Epigenetics: filling in the ‘heritability gap’ and identifying gene-environment interactions in ulcerative colitis. Genome Med. 2012;4(9):72. doi:10.1186/gm373
   PubMed Web of Science ®Google Scholar
• Bilsborough J, Fiorino MF, Henkle BW. Select animal models of colitis and their value in predicting clinical efficacy of biological therapies in ulcerative colitis. Expert Opin Drug Discov. 2020;16:1–11.
   PubMed Web of Science ®Google Scholar
• Silva I, Pinto R, Mateus V. Preclinical study in vivo for new pharmacological approaches in inflammatory bowel disease: a systematic review of chronic model of TNBS-induced colitis. J Clin Med. 2019;8(10):1574. doi:10.3390/jcm8101574
   PubMed Web of Science ®Google Scholar
• Kozik AJ, Nakatsu CH, Chun H, Jones-Hall YL. Comparison of the fecal, cecal, and mucus microbiome in male and female mice after TNBS-induced colitis. PLoS One. 2019;14(11):e0225079. doi:10.1371/journal.pone.0225079
   PubMed Web of Science ®Google Scholar
• Maduzia D, Matuszyk A, Ceranowicz D, et al. The influence of pretreatment with ghrelin on the development of acetic-acid-induced colitis in rats. J Physiol Pharmacol. 2015;66(6):875–885.
   PubMed Web of Science ®Google Scholar
• Rabin BS, Rogers SJ. A cell-mediated immune model of inflammatory bowel disease in the rabbit. Gastroenterology. 1978;75(1):29–33. doi:10.1016/0016-5085(78)93759-9
   PubMed Web of Science ®Google Scholar
• Randhawa PK, Singh K, Singh N, Jaggi AS. A review on chemical-induced inflammatory bowel disease models in rodents. Korean J Physiol Pharmacol. 2014;18(4):279–288. doi:10.4196/kjpp.2014.18.4.279
   PubMed Web of Science ®Google Scholar
• González-Ramírez AE, González-Trujano ME, Orozco-Suárez SA, Alvarado-Vásquez N, López-Muñoz FJ. Nerol alleviates pathologic markers in the oxazolone-induced colitis model. Eur J Pharmacol. 2016;776:81–89. doi:10.1016/j.ejphar.2016.02.036
   PubMed Web of Science ®Google Scholar
• Devkota S, Wang Y, Musch MW, et al.Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10~(-/-) mice. Nature. 2012;487(7405):104–108.
   PubMed Web of Science ®Google Scholar
• Onderdonk AB, Hermos JA, Dzink JL, Bartlett JG. Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology. 1978;74(3):521–526. doi:10.1016/0016-5085(78)90289-5
   PubMed Web of Science ®Google Scholar
• Wu B, Qiang L, Zhang Y, et al. The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-κB signaling. Cell Mol Immunol. 2022;19(2):276–289. doi:10.1038/s41423-021-00810-9
   PubMed Web of Science ®Google Scholar
• Kim S, Lee JY, Shin SG, et al. ESRRA (estrogen related receptor alpha) is a critical regulator of intestinal homeostasis through activation of autophagic flux via gut microbiota. Autophagy. 2021;17(10):2856–2875. doi:10.1080/15548627.2020.1847460
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhu BW, Li X, Li YF, Ye XM, Hu JN. Glycogen-based pH and redox sensitive nanoparticles with ginsenoside Rh(2) for effective treatment of ulcerative colitis. Biomaterials. 2022;280:121077. doi:10.1016/j.biomaterials.2021.121077
   PubMed Web of Science ®Google Scholar
• Yang Y, Zheng X, Wang Y, et al. Human fecal microbiota transplantation reduces the susceptibility to dextran sulfate sodium-induced germ-free mouse colitis. Front Immunol. 2022;13:836542. doi:10.3389/fimmu.2022.836542
   PubMed Web of Science ®Google Scholar
• Li H, Zhang Y, Liu M, et al. Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis. Acta Pharm Sin B. 2022;12(1):228–245. doi:10.1016/j.apsb.2021.04.007
   PubMed Web of Science ®Google Scholar
• Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98(3):694–702. doi:10.1016/0016-5085(90)90290-H
   PubMed Web of Science ®Google Scholar
• Kiesler P, Fuss IJ, Strober W. Experimental models of inflammatory bowel diseases. Cell Mol Gastroenterol Hepatol. 2015;1:154–170. doi:10.1016/j.jcmgh.2015.01.006
   PubMed Web of Science ®Google Scholar
• Das S, Rachagani S, Sheinin Y, et al. Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer. Oncogene. 2015;35(20):2645–2654.
   PubMed Web of Science ®Google Scholar
• Qu S, Fan L, Qi Y, et al. Akkermansia muciniphila alleviates dextran sulfate sodium (DSS)-induced acute colitis by NLRP3 activation. Microbiol Spectr. 2021;9(2):e0073021. doi:10.1128/Spectrum.00730-21
   PubMed Web of Science ®Google Scholar
• Larabi A, Barnich N, Nguyen HTT. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD. Autophagy. 2020;16(1):38–51. doi:10.1080/15548627.2019.1635384
   PubMed Web of Science ®Google Scholar
• Yu W, Wang G, Lu C, et al. Pharmacological mechanism of Shenlingbaizhu formula against experimental colitis. Phytomedicine. 2022;98:153961. doi:10.1016/j.phymed.2022.153961
   PubMed Web of Science ®Google Scholar
• Huang X, Ai F, Ji C, et al. A rapid screening method of candidate probiotics for inflammatory bowel diseases and the anti-inflammatory effect of the selected strain Bacillus smithii XY1. Front Microbiol. 2021;12:760385. doi:10.3389/fmicb.2021.760385
   PubMed Web of Science ®Google Scholar
• Yu W, Su X, Chen W, et al. Three types of gut bacteria collaborating to improve Kui Jie’an enema treat DSS-induced colitis in mice. Biomed Pharmacother. 2019;113:108751. doi:10.1016/j.biopha.2019.108751
   PubMed Web of Science ®Google Scholar
• Dong L, Du H, Zhang M, et al. Anti-inflammatory effect of Rhein on ulcerative colitis via inhibiting PI3K/Akt/mTOR signaling pathway and regulating gut microbiota. Phytother Res. 2022. doi:10.1002/ptr.7429
   Web of Science ®Google Scholar
• Chen J, Zhang LK, Gu WC, et al. Effect of Banxia Xiexin Decoction on intestinal flora of mice with ulcerative colitis induced by dextran sodium sulfate. Zhongguo Zhong Yao Za Zhi. 2021;46(11):2871–2880. doi:10.19540/j.cnki.cjcmm.20210119.401
   PubMedGoogle Scholar
• Rosa F, Matazel KS, Elolimy AA, et al. Human milk-fed piglets have a distinct small intestine and circulatory metabolome profile relative to that of milk formula-fed piglets. mSystems. 2021;6(1). doi:10.1128/mSystems.01376-20
   PubMed Web of Science ®Google Scholar
• van de Guchte M, Mondot S, Doré J. Dynamic properties of the intestinal ecosystem call for combination therapies, targeting inflammation and microbiota, in ulcerative colitis. Gastroenterology. 2021;161(6):1969–1981.e1912. doi:10.1053/j.gastro.2021.08.057
   PubMed Web of Science ®Google Scholar
• Mills RH, Dulai PS, Vázquez-Baeza Y, et al. Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity. Nat Microbiol. 2022;7(2):262–276. doi:10.1038/s41564-021-01050-3
   PubMed Web of Science ®Google Scholar
• Lima SF, Gogokhia L, Viladomiu M, et al. Transferable immunoglobulin A-coated odoribacter splanchnicus in responders to fecal microbiota transplantation for ulcerative colitis limits colonic inflammation. Gastroenterology. 2022;162(1):166–178. doi:10.1053/j.gastro.2021.09.061
   PubMed Web of Science ®Google Scholar
• Jialing L, Yangyang G, Jing Z, et al. Changes in serum inflammatory cytokine levels and intestinal flora in a self-healing dextran sodium sulfate-induced ulcerative colitis murine model. Life Sci. 2020;263:118587. doi:10.1016/j.lfs.2020.118587
   PubMed Web of Science ®Google Scholar
• Wang GH, Dittmer J, Douglas B, Huang L, Brucker RM. Coadaptation between host genome and microbiome under long-term xenobiotic-induced selection. Sci Adv. 2021;7(19). doi:10.1126/sciadv.abd4473
   Web of Science ®Google Scholar
• Huang H, Jiang Y, Zhao J, Li S, Schulz S, Deng L. BTEX biodegradation is linked to bacterial community assembly patterns in contaminated groundwater ecosystem. J Hazard Mater. 2021;419:126205. doi:10.1016/j.jhazmat.2021.126205
   PubMed Web of Science ®Google Scholar
• Zheng G, Ma Y, Zou Y, Yin A, Li W, Dong D. HCMDB: the human cancer metastasis database. Nucleic Acids Res. 2018;46(D1):D950–d955. doi:10.1093/nar/gkx1008
   PubMed Web of Science ®Google Scholar
• Zhang X, Johnston ER, Barberán A, Ren Y, Lü X, Han X. Decreased plant productivity resulting from plant group removal experiment constrains soil microbial functional diversity. Glob Chang Biol. 2017;23(10):4318–4332. doi:10.1111/gcb.13783
   PubMed Web of Science ®Google Scholar
• Eichele DD, Kharbanda KK. Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol. 2017;23(33):6016–6029. doi:10.3748/wjg.v23.i33.6016
   PubMed Web of Science ®Google Scholar
• Gaudio E, Taddei G, Vetuschi A, et al. Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig Dis Sci. 1999;44(7):1458–1475. doi:10.1023/A:1026620322859
   PubMed Web of Science ®Google Scholar
• Nishihara Y, Ogino H, Tanaka M, et al. Mucosa-associated gut microbiota reflects clinical course of ulcerative colitis. Sci Rep. 2021;11(1):13743. doi:10.1038/s41598-021-92870-0
   PubMed Web of Science ®Google Scholar
• Mei Z, Huang X, Zhang H, et al. Chitin derivatives ameliorate DSS-induced ulcerative colitis by changing gut microbiota and restoring intestinal barrier function. Int J Biol Macromol. 2022;202:375–387. doi:10.1016/j.ijbiomac.2022.01.049
   PubMed Web of Science ®Google Scholar
• Li Q, Ding X, Liu K, et al. Fecal microbiota transplantation for ulcerative colitis: the optimum timing and gut microbiota as predictors for long-term clinical outcomes. Clin Transl Gastroenterol. 2020;11(8):e00224. doi:10.14309/ctg.0000000000000224
   PubMedGoogle Scholar
• Cui L, Guan X, Ding W, et al. Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota. Int J Biol Macromol. 2021;166:1035–1045. doi:10.1016/j.ijbiomac.2020.10.259
   PubMed Web of Science ®Google Scholar
• Wu M, Li P, An Y, et al. Phloretin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the gut microbiota. Pharmacol Res. 2019;150:104489. doi:10.1016/j.phrs.2019.104489
   PubMed Web of Science ®Google Scholar
• Yu P, Ke C, Guo J, Zhang X, Li B. Lactobacillus plantarum L15 alleviates colitis by inhibiting LPS-mediated NF-κB activation and ameliorates DSS-induced gut microbiota dysbiosis. Front Immunol. 2020;11:575173. doi:10.3389/fimmu.2020.575173
   PubMed Web of Science ®Google Scholar
• El-Baz AM, Khodir AE, Adel El-Sokkary MM, Shata A. The protective effect of Lactobacillus versus 5-aminosalicylic acid in ulcerative colitis model by modulation of gut microbiota and Nrf2/Ho-1 pathway. Life Sci. 2020;256:117927. doi:10.1016/j.lfs.2020.117927
   PubMed Web of Science ®Google Scholar
• Jeon SG, Kayama H, Ueda Y, et al. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog. 2012;8(5):e1002714. doi:10.1371/journal.ppat.1002714
   PubMed Web of Science ®Google Scholar
• Imaoka A, Shima T, Kato K, et al. Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J Gastroenterol. 2008;14(16):2511–2516. doi:10.3748/wjg.14.2511
   PubMed Web of Science ®Google Scholar
• Bian X, Wu W, Yang L, et al. Administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. Front Microbiol. 2019;10:2259. doi:10.3389/fmicb.2019.02259
   PubMed Web of Science ®Google Scholar
• Wang G, Liu Y, Lu Z, et al. The ameliorative effect of a Lactobacillus strain with good adhesion ability against dextran sulfate sodium-induced murine colitis. Food Funct. 2019;10(1):397–409. doi:10.1039/C8FO01453A
   PubMed Web of Science ®Google Scholar
• Ma X, Hu Y, Li X, et al. Periplaneta americana ameliorates dextran sulfate sodium-induced ulcerative colitis in rats by Keap1/Nrf-2 activation, intestinal barrier function, and gut microbiota regulation. Front Pharmacol. 2018;9:944. doi:10.3389/fphar.2018.00944
   PubMed Web of Science ®Google Scholar
• Bornet E, Westermann AJ. The ambivalent role of Bacteroides in enteric infections. Trends Microbiol. 2022;30(2):104–108. doi:10.1016/j.tim.2021.11.009
   PubMed Web of Science ®Google Scholar
• Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122(1):107–118. doi:10.1016/j.cell.2005.05.007
   PubMed Web of Science ®Google Scholar
• Im E, Jung J, Pothoulakis C, Rhee SH. Disruption of Pten speeds onset and increases severity of spontaneous colitis in Il10(-/-) mice. Gastroenterology. 2014;147(3):667–679.e610. doi:10.1053/j.gastro.2014.05.034
   PubMed Web of Science ®Google Scholar
• Ming J, Yu X, Xu X, et al. Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study. Genome Med. 2021;13(1):125. doi:10.1186/s13073-021-00942-7
   PubMed Web of Science ®Google Scholar
• Reghu S, Miyako E. Nanoengineered bifidobacterium bifidum with optical activity for photothermal cancer immunotheranostics. Nano Lett. 2022;22:1880–1888. doi:10.1021/acs.nanolett.1c04037
   PubMed Web of Science ®Google Scholar
• Groeger D, O’Mahony L, Murphy EF, et al. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes. 2013;4(4):325–339. doi:10.4161/gmic.25487
   PubMed Web of Science ®Google Scholar
• Liwinski T, Casar C, Ruehlemann MC, et al. A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis. Aliment Pharmacol Ther. 2020;51(12):1417–1428. doi:10.1111/apt.15754
   PubMed Web of Science ®Google Scholar
• Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut. 2005;54(2):242–249. doi:10.1136/gut.2004.044834
   PubMed Web of Science ®Google Scholar
• Yang C, Jie L, Si-min Z, et al. Effect of Gegen Qinlian Decoction and it’s different compatibility groups on gut microbiota in rats with acute enteritis based on high-throughput sequencing. China J Chin Materia Medica. 2020;45(06):1406–1417. doi:10.19540/j.cnki.cjcmm.20191112.401
   Google Scholar
• Chen L, Wang W, Zhou R, et al. Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease. Medicine. 2014;93(8):e51. doi:10.1097/MD.0000000000000051
   PubMed Web of Science ®Google Scholar
• Yang WY, Lee Y, Lu H, Chou CH, Wang C. Analysis of gut microbiota and the effect of lauric acid against necrotic enteritis in Clostridium perfringens and Eimeria side-by-side challenge model. PLoS One. 2019;14(5):e0205784. doi:10.1371/journal.pone.0205784
   PubMed Web of Science ®Google Scholar
• Ghosh SS, Gehr TW, Ghosh S, et al. PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase. Kidney Int. 2003;64(1):52–62. doi:10.1046/j.1523-1755.2003.00054.x
   PubMed Web of Science ®Google Scholar
• Nowak JK, Adams AT, Kalla R, et al. Characterization of the circulating transcriptomic landscape in inflammatory bowel disease provides evidence for dysregulation of multiple transcription factors including NFE2, SPI1, CEBPB, and IRF2. J Crohns Colitis. 2022. doi:10.1093/ecco-jcc/jjac033
   PubMed Web of Science ®Google Scholar
• Uchiyama K, Takagi T, Mizushima K, et al. Mucosal interleukin-8 expression as a predictor of subsequent relapse in UC patients with MES 0. J Gastroenterol Hepatol. 2022. doi:10.1111/jgh.15813
   Web of Science ®Google Scholar
• Zhang L. Exploring the Mechanism of Banxia Xiexin Decoction and Its Decomposed Recipes for Treatment of Ulcerative Colitis Based on Gut Microbiota. [Dissertation]. Shandong University of Traditional Chineae Medicine; 2021.
   Google Scholar
• Ren T, Ren M, Ren X, Ren P, Lin Y, Lin W. Characteristics of alter 5-Hydroxytryptamine signaling in colonic mucosa of patients with ulcerative colitis. Int J Digest Dis. 2019;39(03):222–227.
   Google Scholar
• Wu PH, Chiu YW, Zou HB, et al. Exploring the benefit of 2-methylbutyric acid in patients undergoing hemodialysis using a cardiovascular proteomics approach. Nutrients. 2019;11(12):3033. doi:10.3390/nu11123033
   PubMed Web of Science ®Google Scholar
• Ichikawa N, Sasaki H, Lyu Y, et al. Cold exposure during the active phase affects the short-chain fatty acid production of mice in a time-specific manner. Metabolites. 2021;12(1):20. doi:10.3390/metabo12010020
   PubMed Web of Science ®Google Scholar
• Dass NB, John AK, Bassil AK, et al. The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation. Neurogastroenterol Motil. 2007;19(1):66–74. doi:10.1111/j.1365-2982.2006.00853.x
   PubMed Web of Science ®Google Scholar
• Hecker M, Sommer N, Mayer K. Assessment of short- and medium-chain fatty acids on mitochondrial function in severe inflammation. Methods Mol Biol. 2015;1265:389–396.
   PubMedGoogle Scholar
• Hecker M, Sommer N, Mayer K. Assessment of short- and medium-chain fatty acids on mitochondrial function in severe inflammation. Methods Mol Biol. 2021;2277:125–132.
   PubMedGoogle Scholar
• Wang J, Li M, Gao Y, et al. Effects of Exopolysaccharides from Lactiplantibacillus plantarum JLAU103 on intestinal immune response, oxidative stress, and microbial communities in cyclophosphamide-induced immunosuppressed mice. J Agric Food Chem. 2022;70(7):2197–2210. doi:10.1021/acs.jafc.1c06502
   PubMed Web of Science ®Google Scholar
• Schlatterer K, Peschel A, Kretschmer D. Short-chain fatty acid and FFAR2 activation - a new option for treating infections? Front Cell Infect Microbiol. 2021;11:785833. doi:10.3389/fcimb.2021.785833
   PubMed Web of Science ®Google Scholar
• Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63(8):1275–1283. doi:10.1136/gutjnl-2013-304833
   PubMed Web of Science ®Google Scholar
• Bajic D, Niemann A, Hillmer AK, et al. Gut microbiota-derived propionate regulates the expression of Reg3 mucosal lectins and ameliorates experimental colitis in mice. J Crohns Colitis. 2020;14(10):1462–1472. doi:10.1093/ecco-jcc/jjaa065
   PubMed Web of Science ®Google Scholar
• Magnusson MK, Isaksson S, Öhman L. The anti-inflammatory immune regulation induced by butyrate is impaired in inflamed intestinal mucosa from patients with ulcerative colitis. Inflammation. 2020;43(2):507–517. doi:10.1007/s10753-019-01133-8
   PubMed Web of Science ®Google Scholar
• Russo E, Giudici F, Fiorindi C, Ficari F, Scaringi S, Amedei A. Immunomodulating activity and therapeutic effects of short chain fatty acids and tryptophan post-biotics in inflammatory bowel disease. Front Immunol. 2019;10:2754. doi:10.3389/fimmu.2019.02754
   PubMed Web of Science ®Google Scholar
• Sayed IM, Ibeawuchi SR, Lie D, et al. The interaction of enteric bacterial effectors with the host engulfment pathway control innate immune responses. Gut Microbes. 2021;13(1):1991776. doi:10.1080/19490976.2021.1991776
   PubMed Web of Science ®Google Scholar